Opzelura and Pain - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Opzelura?
Opzelura has active ingredients of ruxolitinib phosphate. Currently, eHealthMe is studying from 889 Opzelura users.
What is Pain?
Pain is found to be associated with 5,320 drugs and 5,716 conditions by eHealthMe. Currently, we are studying 1,088,462 people who have Pain.
Do you take Opzelura and have Pain?Check whether Pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Pain and when was it recovered:
Expand to all the drugs that have ingredients of ruxolitinib phosphate:
- Pain and drugs with ingredients of ruxolitinib phosphate (1,063 reports)
Alternative drugs to, pros and cons of Opzelura:
- Opzelura (889 reports)
Browse all side effects of Opzelura:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pain treatments and more:
- Pain (1,088,462 reports)
All the drugs that are associated with Pain:
All the conditions that are associated with Pain:
How the study uses the data?
The study uses data from the FDA. It is based on ruxolitinib phosphate (the active ingredients of Opzelura) and Opzelura (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Topicort and Fibromyalgia - 14 seconds ago
- Azelastine and Central Nervous System Lesion - 21 seconds ago
- Diclofenac Potassium and Bextra drug interaction - 22 seconds ago
- Levaquin and Bradycardia - 23 seconds ago
- Methylprednisolone and Buspirone Hcl drug interaction - 25 seconds ago
- Indocin and Seroquel drug interaction - 26 seconds ago
- Ziac and Nasopharyngitis - 30 seconds ago
- Diflucan and Concomitant Disease Aggravated - 34 seconds ago
- Vitamin D and Atelectasis - 42 seconds ago
- Clopidogrel Bisulfate and Glucagon drug interaction - 46 seconds ago